CheckMate-9LA study of Opdivo plus low-dose Yervoy in first-line NSCLC meets primary endpoint Oct. 23, 2019
Provention reports phase IIa topline results for PRV-6527 in moderate to severe Crohn's disease Oct. 23, 2019
Response to treatment observed in phase Ib/II trial of onvansertib in KRAS-mutated colorectal cancer Oct. 23, 2019
RSS